Literature DB >> 2573278

The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP.

D K Grandy1, M Litt, L Allen, J R Bunzow, M Marchionni, H Makam, L Reed, R E Magenis, O Civelli.   

Abstract

Human dopaminergic neurons are involved in the control of hormone secretion, voluntary movement, and emotional behavior. Mediating these effects are the dopamine D1 and D2 receptors. These macromolecules belong to a large family of related sequences known as the G protein-coupled receptors. The D2 receptors have been of special interest because they bind, with high affinity and specificity, many of the commonly prescribed antipsychotic drugs. We previously isolated a full-length cDNA clone of the rat D2 receptor. When a chromosome mapping panel was probed with the rat D2 receptor cDNA a 15-kb EcoRI restriction fragment was identified and localized to human chromosome 11. The rat cDNA was also used to clone a human genomic fragment, lambda hD2G1, which contains the last coding exon of the D2 receptor gene (DRD2) and 16.5 kb of 3' flanking sequence. Hybridization of lambda hD2G1 to a chromosome 11 regional mapping panel localized DRD2 to 11q. In situ hybridization of lambda hD2G1 to metaphase chromosomes refined this assignment to the q22-q23 junction of chromosome 11. A search for RFLPs associated with D2DR identified a frequent two-allele TaqI RFLP.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2573278      PMCID: PMC1683432     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  22 in total

Review 1.  Role of brain monoamines and histamine in regulation of anterior pituitary secretion.

Authors:  R I Weiner; W F Ganong
Journal:  Physiol Rev       Date:  1978-10       Impact factor: 37.312

2.  Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons.

Authors:  P Seeman; T Lee
Journal:  Science       Date:  1975-06-20       Impact factor: 47.728

3.  Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

Authors:  I Creese; D R Burt; S H Snyder
Journal:  Science       Date:  1976-04-30       Impact factor: 47.728

4.  Simultaneous fluorescent staining of R bands and specific heterochromatic regions (DA-DAPI bands) in human chromosomes.

Authors:  D Schweizer
Journal:  Cytogenet Cell Genet       Date:  1980

5.  Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency.

Authors:  S J Peroutka; S H Synder
Journal:  Am J Psychiatry       Date:  1980-12       Impact factor: 18.112

6.  Simultaneous observation of quinacrine bands and silver grains on radiolabeled metaphase chromosomes.

Authors:  V L Sawin; A M Skalka; W Wray
Journal:  Histochemistry       Date:  1978-12-28

7.  Receptor basis for dopaminergic supersensitivity in Parkinson's disease.

Authors:  T Lee; P Seeman; A Rajput; I J Farley; O Hornykiewicz
Journal:  Nature       Date:  1978-05-04       Impact factor: 49.962

8.  Functional delineation of hyperprolactinemic-amenorrhea.

Authors:  G C Lachelin; S Abu-fadil; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1977-06       Impact factor: 5.958

9.  Localization of single copy DNA sequences of G-banded human chromosomes by in situ hybridization.

Authors:  M E Harper; G F Saunders
Journal:  Chromosoma       Date:  1981       Impact factor: 4.316

Review 10.  Mechanisms of signal transduction at the dopamine D2 receptor.

Authors:  L Vallar; J Meldolesi
Journal:  Trends Pharmacol Sci       Date:  1989-02       Impact factor: 14.819

View more
  79 in total

1.  Association of a missense change in the D2 dopamine receptor with myoclonus dystonia.

Authors:  C Klein; M F Brin; P Kramer; M Sena-Esteves; D de Leon; D Doheny; S Bressman; S Fahn; X O Breakefield; L J Ozelius
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  PharmGKB summary: dopamine receptor D2.

Authors:  Huaiyu Mi; Paul D Thomas; Huijun Z Ring; Ruhong Jiang; Katrin Sangkuhl; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-06       Impact factor: 2.089

3.  Dopamine D2 receptor polymorphisms in inflammatory bowel disease and the refractory response to treatment.

Authors:  F Magro; E Cunha; F Araujo; E Meireles; P Pereira; M Dinis-Ribeiro; F Tavarela Veloso; R Medeiros; P Soares-da-Silva
Journal:  Dig Dis Sci       Date:  2006-09-15       Impact factor: 3.199

4.  Polymorphisms in the DBH and DRD2 gene regions and smoking behavior.

Authors:  Maria Teresa M V Freire; Francine Z C Marques; Mara H Hutz; Claiton H D Bau
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-07-21       Impact factor: 5.270

5.  Contributions of the DAT1 and DRD2 genes to serious and violent delinquency among adolescents and young adults.

Authors:  Guang Guo; Michael E Roettger; Jean C Shih
Journal:  Hum Genet       Date:  2006-10-31       Impact factor: 4.132

6.  Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphisms.

Authors:  Cüneyt Güzey; Maria Gabriella Scordo; Edoardo Spina; Veslemøy Malm Landsem; Olav Spigset
Journal:  Eur J Clin Pharmacol       Date:  2007-01-17       Impact factor: 2.953

Review 7.  From dopaminergic genes to psychiatric disorders.

Authors:  Janet Hoenicka; María Aragüés; Guillermo Ponce; Roberto Rodríguez-Jiménez; Miguel A Jiménez-Arriero; Tomás Palomo
Journal:  Neurotox Res       Date:  2007-01       Impact factor: 3.911

Review 8.  DNA and classical genetic markers in schizophrenia.

Authors:  M J Owen; P McGuffin
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

9.  An Alu polymorphism intragenic to the TP53 gene.

Authors:  P A Futreal; J C Barrett; R W Wiseman
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

10.  Assessment of association between the dopamine D2 receptor (DRD2) polymorphism and neurodevelopment of children exposed to lead.

Authors:  Lian Liu; Xijin Xu; Taofeek Akangbe Yekeen; Kun Lin; Weiqiu Li; Xia Huo
Journal:  Environ Sci Pollut Res Int       Date:  2014-01-28       Impact factor: 4.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.